The Food and Drug Safety Ministry (MFDS) has published the results of its regular inspection of institutions that conduct drug clinical trials. The survey identified compliance issues that require corrective action at five facilities: Kyung Hee University Hospital, Joheung Kang‑an Hospital, Dankook University Dental College Hospital, Daegu Hanui Daehanbang Hospital, and Hallym University Han River Seongshim Hospital. In contrast, the Korea University College of Medicine Affiliated Hospital was found to have no identified issues. The inspection was carried out in accordance with Article 34 of the Pharmaceutical Affairs Act and related regulations, aiming to verify adherence to Good Clinical Practice (GCP) and fulfillment of designated requirements. On‑site visits were conducted at each institution as part of the assessment process.
Regulatory UpdatesSep 21, 2026•1 min read
MFDS Survey Flags Issues at Five Korean Clinical Trial Sites
MFDS’ recent survey identified corrective findings at five hospitals, while Korea University Medical Center had no issues.
Compiled by the PharmaCountry team · Source: KPA News
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating